{"result": "(\"entity\"<|>DA DE LUIS<|>PERSON<|>DA de Luis is a researcher involved in multiple clinical trials related to enteral nutrition and cancer treatment.)\n##\n(\"entity\"<|>O IZAOLA<|>PERSON<|>O Izaola is a researcher who co-authored studies on enteral nutrition in cancer patients.)\n##\n(\"entity\"<|>R ALLER<|>PERSON<|>R Aller is a researcher contributing to studies on nutritional interventions in cancer patients.)\n##\n(\"entity\"<|>L CUELLAR<|>PERSON<|>L Cuellar is a researcher involved in clinical trials focusing on enteral nutrition.)\n##\n(\"entity\"<|>MC TERROBA<|>PERSON<|>MC Terroba is a researcher who has co-authored studies on enteral nutrition and cancer.)\n##\n(\"entity\"<|>HOSPITAL UNIVERSITARIO REINA SOFÍA<|>ORGANIZATION<|>Hospital Universitario Reina Sofía is a clinical institution in Córdoba where research on nutrition and cancer is conducted.)\n##\n(\"entity\"<|>CÓRDOBA<|>GEO<|>Córdoba is a city in Spain where the Hospital Universitario Reina Sofía is located.)\n##\n(\"entity\"<|>CÁNCER GÁSTRICO<|>EVENT<|>Cáncer gástrico refers to the medical condition of gastric cancer, which is a focus of nutritional studies.)\n##\n(\"entity\"<|>CÁNCER DE ESÓFAGO<|>EVENT<|>Cáncer de esófago refers to esophageal cancer, which is also studied in relation to nutrition.)\n##\n(\"entity\"<|>CÁNCER DE PÁNCREAS<|>EVENT<|>Cáncer de páncreas refers to pancreatic cancer, another area of focus in nutritional research.)\n##\n(\"relationship\"<|>DA DE LUIS<|>HOSPITAL UNIVERSITARIO REINA SOFÍA<|>DA de Luis conducts research on enteral nutrition at the Hospital Universitario Reina Sofía<|>8)\n##\n(\"relationship\"<|>O IZAOLA<|>HOSPITAL UNIVERSITARIO REINA SOFÍA<|>O Izaola collaborates on research at the Hospital Universitario Reina Sofía<|>8)\n##\n(\"relationship\"<|>R ALLER<|>HOSPITAL UNIVERSITARIO REINA SOFÍA<|>R Aller is involved in clinical trials at the Hospital Universitario Reina Sofía<|>8)\n##\n(\"relationship\"<|>L CUELLAR<|>HOSPITAL UNIVERSITARIO REINA SOFÍA<|>L Cuellar conducts studies at the Hospital Universitario Reina Sofía<|>8)\n##\n(\"relationship\"<|>MC TERROBA<|>HOSPITAL UNIVERSITARIO REINA SOFÍA<|>MC Terroba is a researcher at the Hospital Universitario Reina Sofía<|>8)\n##\n(\"relationship\"<|>CÁNCER GÁSTRICO<|>HOSPITAL UNIVERSITARIO REINA SOFÍA<|>Research on cáncer gástrico is conducted at the Hospital Universitario Reina Sofía<|>7)\n##\n(\"relationship\"<|>CÁNCER DE ESÓFAGO<|>HOSPITAL UNIVERSITARIO REINA SOFÍA<|>Research on cáncer de esófago is conducted at the Hospital Universitario Reina Sofía<|>7)\n##\n(\"relationship\"<|>CÁNCER DE PÁNCREAS<|>HOSPITAL UNIVERSITARIO REINA SOFÍA<|>Research on cáncer de páncreas is conducted at the Hospital Universitario Reina Sofía<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: . Guidelines for the use of parenteral\n     scope of the problem. Nat Rev Gastroenterol He-                            and enteral nutrition in adult and pediatric pa-\n     patol. 2015 May; 12(5):259-70.                                             tients. JPEN 2002; 26 (Supp).\n18.  DA de Luis, O Izaola, R Aller, L Cuellar, MC Terro-                  29.   Valentini L, Schütz T, Allison S, Howard P, Pichard\n     ba. Randomized clinical trial with an enteral argi-                        C, Lochs H. ESPEN Guidelines on enteral nutrition.\n     nine-enhanced formula in early postsurgical. Eur J                         Clin Nutr. 2006; 25:260-74.\n     Clin Nutr 2004; 58:1505-1508.                                        30.   Weimann A, Braga M, HArsanyi L, Laviano A, Ljun-\n19.  DA de Luis, O izaola, R Aller, L Cuellar, MC Terro-                        gqvist O, Soeters P. ESPEN guidelines on enteral\n     ba. Postsurgery enteral immunonutrition in head                            nutrition: surgery including organ transplantation.\n     and neck cancer patients. Eur J Clin Nutr 2002. 56,                        Clinical Nutrition 2006; 26:224-244.\n                                                                                De Luis DA1, Izaola O, Terroba MC, Cuellar L, Ventosa\n     1126-1129.                                                           31.\n20.  DA de Luis, O Izaola, L Cuellar, MC Terroba, T Mar-                        M, Martin T Effect of three different doses of argini-\n     tin, R Aller. Clinical and biochemical outcomes af-                        ne enhanced enteral nutrition on nutritional status\n     ter a randomized trial with a high dose of enteral                         and outcomes in well-nourished postsurgical cancer\n     arginine formula in postsurgical head and neck                             patients: a randomized single blinded prospective\n     cancer patients. E J Clin Nutr 2006; 1-5.                                  trial. Eur Rev Med Pharmacol Sci. 2015; 19:950-5.\n21.  DA de Luis, O izaola, R Aller, L Cuellar, MC Terro-                  32.   Buijs N, van Bokhorst-de van der Schueren MA,\n     ba. Immunoenhanced enteral nutrition, effect on                            Langius JA, Leemans CR, Kuik DJ, Vermeulen MA,\n     inflammatory markers in head and neck cancer                               van Leeuwen PA. Perioperative arginine-supple-\n     patients Eur J Clin Nutr 2005; 59:145-147.                                 mented nutrition in malnourished patients with\n22.  DA de Luis, O Izaola, R Aller, L Cuellar, MC Terro-                        head and neck cancer improves long-term survival.\n     ba. Randomized clinical trial with an enteral argi-                        Am J Clin Nutr. 2010; 92:1151-6.\n     nine-enhanced formula in early postsurgical. Eur J                   33.   Langius JA, Zandbergen MC, Eerenstein SE, van Tul-\n     Clin Nutr 2004; 58:1505-1508.                                              der MW, Leemans CR, Kramer MH, Weijs PJ Effect\n23.  de Luis DA, Izaola O, Aller R, Cuellar L, Terroba                          of nutritional interventions on nutritional status,\n     MC, Martin M. A randomized clinical trial with                             quality of life and mortality in patients with head\n---\n 616     BLOQUE: NUTRICIÓN EN ONCOLOGÍA\n\n\n\n      and neck cancer receiving (chemo)radiotherapy: a     dysgeusia, oral mucositis and xerostomia on nutri-\n      systematic review. Clin Nutr. 2013; 32:671-8.        tional status, oral intake and weight loss in head\n34.   Bressan V, Stevanin S, Bianchi M, Aleo G, Bagnas-    and neck cancer patients: A systematic review.\n      co A, Sasso L. The effects of swallowing disorders,  Cancer Treat Rev. 2016; 45:105-19.\n---\nTema 39.\nSoporte nutricional en el paciente con cirugía\noncológica de estómago, esófago y páncreas\nAlfonso Calañas-Continente\nUnidad de Gestión Clínica de Endocrinología y Nutrición. Hospital Universitario Reina Sofía. Córdoba\n\n\n\nDietoterapia, nutrición clínica y metabolismo. Tercera edición. Copyright 2017 de los autores, SEEN y Grupo Aula Médica.\nTodos los derechos reservados. Páginas 617-634.\n\n\n\n   1.  Bases del tratamiento de la malnutrición relacionada con el cáncer\n   2.  Cáncer gástrico\n   3.  Cáncer de esófago\n   4.  Cáncer de páncreas\n   5.  Resumen\n   6.  Bibliografía\n\n\n\n   Las neoplasias gastrointestinales son la causa más                          Se    recomienda       la   intervención\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}